Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 289, Issue 4 33-4, 2005, Pages

  Kunig, Anette M ^a,b   Balasubramaniam, Vivek ^a   Markham, Neil E ^a   Morgan, Danielle ^a   Montgomery, Greg ^a   Grover, Theresa R ^a   Abman, Steven H ^a  

^a CHILDREN S HOSPITAL   (United States)

^b Children's Hospital Colorado   (United States)

Author keywords

Angiogenesis; Bronchopulmonary dysplasia; Lung development; Vascular endothelial growth factor

Indexed keywords

RECOMBINANT VASCULOTROPIN; SODIUM CHLORIDE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DENSITY; DRUG MECHANISM; EXPERIMENTAL MODEL; HUMAN; HYPOXIA; LUNG ALVEOLUS; LUNG DYSPLASIA; LUNG INJURY; LUNG STRUCTURE; MORPHOMETRICS; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; BRONCHOPULMONARY DYSPLASIA; FEMALE; HUMANS; HYPEROXIA; INFANT, NEWBORN; NEOVASCULARIZATION, PHYSIOLOGIC; ORGAN SIZE; PREGNANCY; PULMONARY ALVEOLI; PULMONARY CIRCULATION; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 25444484419     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00336.2004     Document Type: Article

References (46)

1. Abman SH. Bronchopulmonary dysplasia: "a vascular hypothesis". Am J Respir Crit Care Med 164: 1755-1756, 2001.
2. Afshar S, Gibson LL, Yuhanna IS, Sherman TS, Kerecman JD, Grubb PH, Yoder BA, McCurnin DC, and Shaul PW. Pulmonary NO synthase expression is attenuated in a fetal baboon model of chronic lung disease. Am J Physiol Lung Cell Mol Physiol 284: L749-L758, 2003.
3. Bachofen H, Ammann A, Wangensteen D, and Weibel ER. Perfusion fixation of lungs for structure-function analysis: credits and limitations. J Appl Physiol 53: 528-533, 1982.
4. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, and Maniscalco WM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 164: 1971-1980, 2001.
5. Brown KR, England KM, Goss KL, Snyder JM, and Acarregui MJ. VEGF induces airway epithelial cell proliferation in human fetal lung in vitro. Am J Physiol Lung Cell Mol Physiol 281: L1001-L1010, 2001.
6. Bucher JR and Roberts RJ. The development of the newborn rat lung in hyperoxia: a dose-response study of lung growth, maturation, and changes in antioxidant enzyme activities. Pediatr Res 15: 999-1008, 1981.
7. Chen Y, Whitney PL, and Frank L. Comparative responses of premature versus full-term newborn rats to prolonged hyperoxia. Pediatr Res 35: 233-237, 1994.
8. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, Plaisance S, Dor Y, Keshet E, Lupu F, Nemery B, Dewerchin M, Van Veldhoven P, Plate K, Moons L, Collen D, and Carmeliet P. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 8: 702-710, 2002.
9. Cooney TP and Thurlbeck WM. The radial alveolar count method of Emery and Mithal: a reappraisal 1-postnatal lung growth. Thorax 37: 572-579, 1982.
10. Cooney TP and Thurlbeck WM. The radial alveolar count method of Emery and Mithal: a reappraisal 2-intrauterine and early postnatal lung growth. Thorax 37: 580-583, 1982.
11. Ferrara N, Gerber HP, and LeCouter J. The biology of VEGF and its receptors. Nat Med 9: 669-676, 2003.
12. Fulton RM, Hutchinson EC, and Jones AM. Ventricular weight in cardiac hypertrophy. Br Heart J 14: 413-420, 1952.
13. Gries DM, Tam EK, Blaisdell JM, Iwamoto LM, Fujiwara N, Uyehara CF, and Nakamura KT. Differential effects of inhaled nitric oxide and hyperoxia on pulmonary dysfunction in newborn guinea pigs. Am J Physiol Regul Integr Comp Physiol 279: R1525-R1530, 2000.
14. Grover TR, Parker TA, Zenge JP, Markham NE, Kinsella JP, and Abman SH. Intrauterine hypertension decreases lung VEGF expression and VEGF inhibition causes pulmonary hypertension in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 284: L508-L517, 2003.
15. Hayatdavoudi G, Crapo JD, Miller FJ, and O'Neil JJ. Factors determining degree of inflation in intratracheally fixed rat lungs. J Appl Physiol 48: 389-393, 1980.
16. Hood JD, Meininger CJ, Ziche M, and Granger HJ. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol Heart Circ Physiol 274: H1054-H1058, 1998.
17. Hosford GE and Olson DM. Effects of hyperoxia on VEGF, its receptors, and HIF-2alpha in the newborn rat lung. Am J Physiol Lung Cell Mol Physiol 285: L161-L168, 2003.
18. Husain AN, Siddiqui NH, and Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 29: 710-717, 1998.
19. Issa A, Lappalainen U, Kleinman M, Bry K, and Hallman M. Inhaled nitric oxide decreases hyperoxia-induced surfactant abnormality in preterm rabbits. Pediatr Res 45: 247-254, 1999.
20. Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, and Abman SH. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 279: L600-L607, 2000.
21. Jobe AH and Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163: 1723-1729, 2001.
22. Kaner RJ, Ladetto JV, Singh R, Fukuda N, Matthay MA, and Crystal RG. Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am J Respir Cell Mol Biol 22: 657-664, 2000.
23. Klekamp JG, Jarzecka K, and Perkett EA. Exposure to hyperoxia decreases the expression of vascular endothelial growth factor and its receptors in adult rat lungs. Am J Pathol 154: 823-831, 1999.
24. Lassus P, Turanlahti M, Heikkila P, Andersson LC, Nupponen I, Sarnesto A, and Andersson S. Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 164: 1981-1987, 2001.
25. Le Cras TD, Markham NE, Tuder RM, Voelkel NF, and Abman SH. Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol Lung Cell Mol Physiol 283: L555-L562, 2002.
26. Le Cras TD, Spitzmiller RE, Albertine KH, Greenberg JM, Whitsett JA, and Akeson AL. VEGF causes pulmonary hemorrhage, hemosiderosis, and air space enlargement in neonatal mice. Am J Physiol Lung Cell Mol Physiol 287: L134-L142, 2004.
27. Lin YJ, Markham NE, Balasubmramaniam VB, Tang JR, Kinsella JP, and Abman SH. Inhaled nitric oxide therapy enhances distal lung growth after exposure to hyperoxia in neonatal rats. Pediatr Res. In press.
28. MacRitchie AN, Albertine KH, Sun J, Lei PS, Jensen SC, Freestone AA, Clair PM, Dahl MJ, Godfrey EA, Carlton DP, and Bland RD. Reduced endothelial nitric oxide synthase in lungs of chronically ventilated preterm lambs. Am J Physiol Lung Cell Mol Physiol 281: L1011-L1020, 2001.
29. Maitre B, Boussat S, Jean D, Gouge M, Brochard L, Housset B, Adnot S, and Delclaux C. Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury. Eur Respir J 18: 100-106, 2001.
30. Maniscalco WM, Watkins RH, D'Angio CT, and Ryan RM. Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung. Am J Respir Cell Mol Biol 16: 557-567, 1997.
31. Maniscalco WM, Watkins RH, Finkelstein JN, and Campbell MH. Vascular endothelial growth factor mRNA increases in alveolar epithelial cells during recovery from oxygen injury. Am J Respir Cell Mol Biol 13: 377-386, 1995.
32. Maniscalco WM, Watkins RH, Pryhuber GS, Bhatt A, Shea C, and Huyck H. Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. Am J Physiol Lung Cell Mol Physiol 282: L811-L823, 2002.
33. Massaro D, Teich N, Maxwell S, Massaro GD, and Whitney P. Postnatal development of alveoli. Regulation and evidence for a critical period in rats. J Clin Invest 76: 1297-1305, 1985.
34. McElroy MC, Wiener-Kronish JP, Miyazaki H, Sawa T, Modelska K, Dobbs LG, and Pittet JF. Nitric oxide attenuates lung endothelial injury caused by sublethal hyperoxia in rats. Am J Physiol Lung Cell Mol Physiol 272: L631-L638, 1997.
35. Mura M, dos Santos CC, Stewart D, and Liu M. Vascular endothelial growth factor and related molecules in acute lung injury. J Appl Physiol 97: 1605-1617, 2004.
36. Nelin LD, Welty SE, Morrisey JF, Gotuaco C, and Dawson CA. Nitric oxide increases the survival of rats with a high oxygen exposure. Pediatr Res 43: 727-732, 1998.
37. Northway WH Jr, Rosan RC and Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 276: 357-368, 1967.
38. Papapetropoulos A, Garcia-Cardena G, Madri JA, and Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100: 3131-3139, 1997.
39. Roberts RJ, Weesner KM, and Bucher JR. Oxygen-induced alterations in lung vascular development in the newborn rat. Pediatr Res 17: 368-375, 1983.
40. Shaffer SG, O'Neill D, Bradt SK, and Thibeault DW. Chronic vascular pulmonary dysplasia associated with neonatal hyperoxia exposure in the rat. Pediatr Res 21: 14-20, 1987.
41. Tang JR, Markham NE, Lin YJ, McMurtry IF, Maxey A, Kinsella JP, and Abman SH. Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Am J Physiol Lung Cell Mol Physiol 287: L344-L351, 2004.
42. Thickett DR, Armstrong L, and Millar AB. A role for vascular endothelial growth factor in acute and resolving lung injury. Am J Respir Crit Care Med 166: 1332-1337, 2002.
43. Tschanz SA and Burri PH. A new approach to detect structural differences in lung parenchyma using digital image analysis. Exp Lung Res 28: 457-471, 2002.
44. Turanlahti M, Pesonen E, Lassus P, and Andersson S. Nitric oxide and hyperoxia in oxidative lung injury. Acta Paediatr 89: 966-970, 2000.
45. Warner BB, Stuart LA, Papes RA, and Wispe JR. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol Lung Cell Mol Physiol 275: L110-L117, 1998.
46. Wilson WL, Mullen M, Olley PM, and Rabinovitch M. Hyperoxia-induced pulmonary vascular and lung abnormalities in young rats and potential for recovery. Pediatr Res 19: 1059-1067, 1985.